QFQiang Xue Fang

Qiang Xue Fang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qiang Xue Fang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 March 2013
      • Vol. 34  (3) , 267-72

    [Economic burden and related factors on inpatients with HBV-related diseases in Shandong province].

    by Jing-Jing Lü, Ren-Peng Li, Ai-Qiang Xu, Li Zhang, Li-Zhi Song, Bing-Yu Yan, Feng Ji, Jia-Ye Liu, Xue-Qiang Fang, Zhen Wang, et al.

    To investigate the economic burden of patients with acute and chronic hepatitis B, cirrhosis and liver cancer caused by hepatitis B virus (HBV). Cluster sampling was used on cases consecutively collected during the study period. Questionnaire survey was conducted and information on the expenses during hospitalization was collected from the hospital records and through interviewing those patients. Yearly costs related to patients with acute hepatitis B, severe hepatitis B, chronic hepatitis B, cirrhosis, hepatocellular carcinoma were 66.7, 138.1, 127.4, 151.7 and 377.2 thousand Yuan, respectively. from multiple linear regression model showed that the type of medical insurance scheme, annual days of hospitalization, classifications of HBV-related diseases and personal income were major influencing factors on the cost. HBV infection caused considerable burden to families and the society, indicating that HBV infection control programs would bring huge potential benefits. The reform of insurance scheme should be administrated to promote social fairness.


  • Open Access

    Varicella vaccine uptake in Shandong province, China

    by Aiqiang Xu, Qing Xu, Xueqiang Fang, Stephanie R Bialek, Chengbin Wang

    Varicella vaccine has been licensed in China for decade to be used as single dose in children aged ≥ 12 mo of age in private sector. Little data were available on varicella uptake to date in China yet. A cross-sectional study was conducted in Shandong Province in May 2011 to examine varicella vaccination coverage among children aged 16–40 mo and examine factors associated with varicella vaccine uptake. The overall coverage among children eligible for varicella vaccine was 62% (range 16.7–94.7% by county), much lower than the coverage of the eight vaccines included in the national immunization program (all above 97%). Though proximity to immunization services (< 5 km) was linked with higher vaccine uptake (62.6 vs. 37.4%, p = 0.02), county-level economic development (77.8, 61.0 and 47.1% for developed, sub-developed and developing regions, respectively, p < 0.001) played an even more important role in varicella vaccination. Moreover, there was little variation in coverage of vaccines included in the national immunization program along with county-level economic development. Even though varicella vaccine uptake is relatively high for use on a private basis, the vaccination coverage is not high enough to prevent epidemiology shift to adolescents and adults who are more prone to develop severe outcomes to varicella. Further enhancement on varicella vaccination coverage is necessary and inclusion to national immunization program seems to be a promising option for achieving and maintaining high coverage.


  • Open Access

    Multi-susceptibility genes associated with the risk of the development stages of esophageal squamous cell cancer in Feicheng County

    by Qing Da Li, Hao Li, Mei Shu Wang, Tao Yu Diao, Zhi Ying Zhou, Qiang Xue Fang, Fang Yan Yang, Qing Hui Li

    The purpose of this study was to evaluate the association of multi-genotype polymorphisms with the stepwise progression of esophageal squamous cell cancer (ESCC) and the possibility of predicting those at higher risk.